IL104699A0 - Ester cleavage process for use with beta-lactams - Google Patents

Ester cleavage process for use with beta-lactams

Info

Publication number
IL104699A0
IL104699A0 IL104699A IL10469993A IL104699A0 IL 104699 A0 IL104699 A0 IL 104699A0 IL 104699 A IL104699 A IL 104699A IL 10469993 A IL10469993 A IL 10469993A IL 104699 A0 IL104699 A0 IL 104699A0
Authority
IL
Israel
Prior art keywords
lactams
beta
ester cleavage
cleavage process
ester
Prior art date
Application number
IL104699A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL104699A0 publication Critical patent/IL104699A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02—Preparation
    • C07D463/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL104699A 1992-02-18 1993-02-11 Ester cleavage process for use with beta-lactams IL104699A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/836,640 US5302711A (en) 1992-02-18 1992-02-18 Ester cleavage process for use with β-lactams

Publications (1)

Publication Number Publication Date
IL104699A0 true IL104699A0 (en) 1993-06-10

Family

ID=25272395

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104699A IL104699A0 (en) 1992-02-18 1993-02-11 Ester cleavage process for use with beta-lactams

Country Status (10)

Country Link
US (1) US5302711A (it)
EP (1) EP0557035A3 (it)
JP (1) JPH05286971A (it)
KR (1) KR930017907A (it)
BR (1) BR9300542A (it)
CA (1) CA2089540A1 (it)
HU (1) HUT64351A (it)
IL (1) IL104699A0 (it)
MX (1) MX9300761A (it)
TW (1) TW232694B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4100908B2 (ja) 1999-07-30 2008-06-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 塩基性抗生物質・無機酸塩の製造法およびシュウ酸塩中間体
CN103588790A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 7-氨基-3-氯-3-头孢-4-羧酸-对硝基苄基酯的制备方法
CN106866704B (zh) * 2017-02-08 2019-06-14 河北科技大学 催化氢化脱除对硝基苄酯以制备7-acca的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1546757A (en) * 1975-04-10 1979-05-31 Lilly Industries Ltd Crystalline cephalosporin salts
JPS52106891A (en) * 1976-03-03 1977-09-07 Shionogi & Co Ltd Removal of carboxyl protecting group
DE2725519A1 (de) * 1977-06-06 1978-12-21 Shionogi & Co Verfahren zur herstellung freier carbonsaeuren durch esterspaltung
IL72412A (en) * 1983-07-22 1988-05-31 Lilly Co Eli Deesterification of beta-lactam antibiotic esters
EP0233255B1 (en) * 1985-08-12 1996-05-29 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
EP0263901A1 (en) * 1986-10-08 1988-04-20 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.
US5043439A (en) * 1990-03-08 1991-08-27 Bristol-Myers Squibb Company Process for production of cephalosporins
US5095107A (en) * 1990-11-05 1992-03-10 Eli Lilly And Company Process for cleavage of esters during the production of cephalosporins

Also Published As

Publication number Publication date
TW232694B (it) 1994-10-21
KR930017907A (ko) 1993-09-20
HU9300384D0 (en) 1993-04-28
JPH05286971A (ja) 1993-11-02
BR9300542A (pt) 1993-08-24
CA2089540A1 (en) 1993-08-19
US5302711A (en) 1994-04-12
EP0557035A2 (en) 1993-08-25
EP0557035A3 (en) 1993-12-01
HUT64351A (en) 1993-12-28
MX9300761A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
AP9300593A0 (en) Process
GB9218346D0 (en) Process
GB9203375D0 (en) Process
IL104699A0 (en) Ester cleavage process for use with beta-lactams
GB9202375D0 (en) Process
AP9300474A0 (en) Process
GB9220068D0 (en) Process
GB9201496D0 (en) Process
GB9215438D0 (en) Process
AP9300473A0 (en) Process
GB9216026D0 (en) Esterification process
GB9218762D0 (en) Esters
GB9317124D0 (en) Process for producing alpha-l-aspartyl-l-phenylanine methyl ester
GB9225202D0 (en) Process
GB9301562D0 (en) Process
GB9220526D0 (en) Process
GB2294930B (en) Process for producing alph-l-aspartyl-l-phenylalanine methyl ester
GB9208720D0 (en) Unvocalised verbalisation process monitor
AU3973393A (en) Desulfurization process using bromine
ZA933757B (en) Cyclopentane-and-pentene-beta-amino acids
GB9221512D0 (en) Phenylpyrazine esters
GB9221636D0 (en) Esters
GB9212036D0 (en) Visual aid for artists
GB9224647D0 (en) Process
GB9215904D0 (en) Process